Status not kept up to date
LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients
NCT02895854 · Kuopio University Hospital · Updated 18 Feb 2021
- What is being tested
- Hypofractionated RT 5 x 7,25 Gy; LDR-brachytherapy with I125 seeds
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 44 people. The full rules are on the registry page.
- Where
- Finland
- When
- Starts or started 8 Jan 2013, ends 31 Dec 2021. Registered 12 Sept 2016.
- Results
- None posted yet.
In the researchers' words
The aim of this trial is to find out if there are any differences in the profiles of acute and late adverse effects among men with low and intermediate risk prostate cancer treated either with low dose-rate brachytherapy or hypofractionated external radiotherapy (CyberKnife). Also the prostate specific antigen (PSA) responses and cost utility of each treatment will be analysed.
Sites
- Kuopio University HospitalKuopio, Finland